Abstract
Control and selection of the properties of active pharmaceutical ingredients is a crucial part of the drug development process. One major part of this process is the selection of an appropriate solid form. This review will discuss three major types of crystalline solids, polymorphs, salts and cocrystals and processes used to develop and find these forms.
Similar content being viewed by others
References
J.W. Mullin, Crystallization, 4th Ed., Butterworth-Heinemann (2001).
L. Yu, G. A. Stephenson, C.A. Mitchell, C.A. Bunnell, S.V. Snorek, J. J. Bowyer, T. B. Borchardt, J.G. Stowell and S. R. Byrn, J. Am. Chem. Soc., 122(4), 585 (2000).
M. R. Caira, In Design of Organic Solids, 198, 163 (1998).
J. Bauer, S. Spanton, R. Henry, J. Quick, W. Dziki, W. Porter and J. Morris, Pharm. Res., 18(6), 859 (2001).
D. J. Kempf, K. C. Marsh, J. F. Denissen, E. Mcdonald, S. Vasavanonda, C.A. Flentge, B. E. Green, L. Fino, C. H. Park, X. P. Kong, N. E. Wideburg, A. Saldivar, L. Ruiz, W. M. Kati, H. L. Sham, T. Robins, K. D. Stewart, A. Hsu, J. J. Plattner, J. M. Leonard and D.W. Norbeck, P. Natl. Acad. Sci., USA, 92(7), 2484 (1995).
D. Law, S. L. Krill, E. A. Schmitt, J. J. Fort, Y. H. Qiu, W. L. Wang and W. R. Porter, J. Pharm. Sci., 90(8), 1015 (2001).
J. Bernstein, Polymorphism in molecular crystals, Clarendon, Oxford (2002).
S. R. Byrn, Solid state chemistry of drugs, Academic, New York (1999).
W. Z. Ostwald, Phys. Chem., 22, 289 (1897).
J. Aaltonen, M. Alleso, S. Mirza, V. Koradia, K. C. Gordon and J. Rantanen, Eur. J. Pharm. Biopharm., 71(1), 23 (2009).
S. L. Morissette, Ö. Almarsson, M. L. Peterson, J. F. Remenar, M. J. Read, A.V. Lemmo, S. Ellis, M. J. Cima and C. R. Gardner, Adv. Drug. Deliv. Rev., 56(3), 275 (2004).
S. Mirza, I. Miroshnyk, J. Heinamaki, L. Christiansen, M. Karjalainen and J. Yliruusi, Aaps. Pharm. Sci., 5(2), 39 (2003).
I. Miroshnyk, L. Khriachtchev, S. Mirza, J. Rantanen, J. Heinamaki and J. Yliruusi, Cryst. Growth Des., 6(2), 369 (2006).
M. D. Hollingsworth, M. L. Peterson, K. L. Pate, B. D. Dinkelmeyer and M. E. Brown, J. Am. Chem. Soc., 124(10), 2094 (2002).
S. L. Childs, L. J. Chyall, J. T. Dunlap, D. A. Coates, B. C. Stahly and G. P. Stahly, Cryst. Growth Des., 4(3), 441 (2004).
B. A. Garetz, J. Matic and A. S. Myerson, Phys. Rev. Lett., 89(17), 175501 (2002).
G. Ruecroft, D. Hipkiss, T. Ly, N. Maxted and P.W. Cains, Org. Proc. Res. Dev., 9(6), 923 (2005).
M. D. Lang, J.W. Kampf and A. J. Matzger, J. Pharm. Sci., 91(4), 1186 (2002).
A.Y. Lee, I. S. Lee, S. S. Dettet, J. Boerner and A. S. Myerson, J. Am. Chem. Soc., 127(43), 14982 (2005).
I. S. Lee, A. Y. Lee and A. S. Myerson, Pharm. Res., 25(4), 960 (2008).
A. Singh, I. S. Lee and A. S. Myerson, Cryst. Growth Des., 9(2), 1182 (2009).
S. M. Berge, L. M. Bighley and D. C. Monkhouse, J. Pharm. Sci., 66, 1 (1977).
P. H. Stahl, G. Wermuth, G. (Eds): Handbook of Pharmaceutical Salts; Properties, Selection and Use (International Union of Pure and Applied Chemistry), New York, Wiley-VCH (2002).
C.B. Aakeroy, M. E. Fasulo and J. Desper, Mol. Pharma., 4(3), 317 (2007).
R. J. Bastin, M. J. Bowker and B. J. Slater, Org. Proc. Res. Dev., 4, 427 (2000).
B. D. Anderson and K. P. Flora, in’The Practice of Medicinal Chemistry’, Ed. C.G. Wermuth, Academic Press Ltd. London, Chapter 34 (1996).
S. F. Kramer and G. L. Flynn, J. Pharm. Sci., 61, 1896 (1972).
A. T. M. Serajuddin, P. C. Sheen, D. Mufson, D. F. Bernstein and M. A. Augustine, J. Pharm. Sci., 75, 492 (1986).
S. Li, P. Doyle, S. Metz, A. E. Royce and A. T. M. Serajuddin, J. Pharma. Sci., 94(10), 2224 (2005).
T. D. Gross, K. Schaab, M. Ouellette, S. Zook, J. P. Reddy, A. Shurtleff, A. I. Sacaan, T. Alebic-Kolbah and H. Bozigian, Org. Proc. Res. Dev., 11, 365 (2007).
J. B. Dressman, P. Bass, W. A. Ritschel, D. R. Friend, A. Rubinstein and E. Ziv, J. Pharm. Sci., 82, 857 (1993).
E. Redenti, L. Szente and J. Szejtli, J. Pharm. Sci., 90(8), 979 (2001).
T. L. Russel, R. R. Berardi, J. L. Barnett, T. L. O’sullivan, J.G. Wagner and J. B. Dressman, Pharm. Res., 11, 136 (1994).
P. L. Gould, Int. J. Pharm., 33, 201 (1986).
C. C. Sun and D. J. Grant, AAPS, Pharm. Sci. Suppl., 1, S–174 (1999).
M. Gazda, R. J. Dansereau, D. J. Crail, D. H. Sakkab and M. M. Virgin, Pharm. Sci., 1, S403 (1998).
R. B. Hammond, R. S. Hashim, C. Ma and K. J. Roberts, J. Pharm. Sci., 95(11), 2361 (2006).
S. N. Black, E. A. Collier, R. J. Davey and R. J. Roberts, J. Pharm. Sci., 96(5), 1053 (2007).
L. R. Madivada, R. R. Anumala, G. Gilla, S. Alla, K. Charagondla, M. Kagga, A. Bhattacharya and R. Bandichhor, Org. Proc. Res. Dev., 13, 1190 (2009).
A. Sallmann, Bottmingen, R. Pfister and B. Switzerland, US3558690 (1971).
R. Bucci, A. D. Magrì, A. L. Magrì and Fresenius, J. Anal. Chem., 362, 577 (1998).
J. Bradshaw, B. J. Price and J.W. Clitherow, GB1565966 (1980).
G. J. Durant, J. C. Emmett and C. R. Ganellin, US3950333 (1976).
H. Yasufumi, Y. Isao, I. Yoshio, T. Shinichi, I. Noriki, I. Yasuo and T. Masaaki, US4283408 (1981).
Ö. Almarsson and M. J. Zaworotko, Chem. Commun., 17, 1889 (2004).
I. Miroshnyk, S. Mirza and N. Sandler, Expt. Opin. Drug Deliv., 6, 333 (2009).
M. C. Etter, J. Phys. Chem., 95, 4601 (1991).
C.C. Seaton, K. Chadwick, G. Sadiq, K. Guo and R. J. Davey, Cryst. Growth Des., 10, 726 (2010).
S. L. Morissettea, Ö. Almarsson, M. L. Peterson, J. F. Remenar, M. J. Read, A.V. Lemmo, S. Ellis, M. J. Cima and C. R. Gardner, Adv. Drug Deliv. Rev., 56, 275 (2004).
A. V. Trask and W. Jones, Top. Curr. Chem., 35, 3523 (2005).
K. Chadwick, R. Davey, G. Sadiq, W. Cross and R. Pritchard, Cryst. Eng. Comm., 11, 412 (2009).
S. J. Nehm, B. Rodríguez-Spong and N. Rodríguez-Hornedo, Cryst. Growth Des., 6, 592 (2006).
J. F. Remenar, M. L. Peterson, P.W. Stephens, Z. Zhang, Y. Zimenkov and M. B. Hickey, Mol. Pharma., 4(3), 386 (2007).
A.V. Trask, W. D. S. Motherwell and W. Jones, Cryst. Growth Des., 5(3), 1013 (2005).
P. Vishweshwar, J. A. McMahon, J. A. Bis and M. J. Zaworotko, J. Pharm. Sci., 95, 499 (2006).
S. L. Childs, L. J. Chyall, J. T. Dunlap, V. N. Smolenskaya, B. C. Stahly and G. P. Stahly, J. Am. Chem. Soc., 126(41), 13335 (2004).
A. Bak, A. Gore, E. Yanez, M. Stanton, S. Tufekcic, R. Syed, A. Akrami, M. Rose, S. Surapaneni, T. Bostick, A. King, S. Neervannan, D. Ostovic and A. Koparkar, J. Pharm. Sci., 97(9), 3942 (2008).
J. F. Remenar, S. L. Morissette, M. L. Peterson, B. Moulton, J. M. MacPhee, H. R. Guzmán and Ö. Almarsson, J. Am. Chem. Soc., 125(28), 8456 (2003).
J. Galcera and E. Molins, Cryst. Growth Des., 9(1), 327 (2009).
N. Shan and M. J. Zaworotko, Drug Discov. Today, 13(9–10), 440 (2008).
N. Schultheiss and A. Newmanwill, Cryst. Growth Des., 9(6), 2950 (2009).
Author information
Authors and Affiliations
Corresponding author
Additional information
Allan S. Myerson is Professor of the Practice of Chemical Engineering in the Department of Chemical Engineering at the Massachusetts Institute of Technology. Professor Myerson was educated at Columbia University (BS) the University of Virginia (MS and PhD). Professor Myerson research focuses on separations processes in the chemical and pharmaceutical industry with an emphasis on crystallization from solution. Professor Myerson is a co-PI in the, Novartis-MIT Center for Continuous Manufacturing. He has published 5 books including the “Handbook of Industrial Crystallization” 158 papers and is the inventor on 32 US patents. Professor Myerson has consulted for approximately 100 companies worldwide and was honored in 2008 with the American Chemical Society Award in Separations Science and Technology.
Rights and permissions
About this article
Cite this article
Sarma, B., Chen, J., Hsi, HY. et al. Solid forms of pharmaceuticals: Polymorphs, salts and cocrystals. Korean J. Chem. Eng. 28, 315–322 (2011). https://doi.org/10.1007/s11814-010-0520-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11814-010-0520-0